ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

RA CAPITAL MANAGEMENT, L.P.'s Holding History (CIK: 0001346824)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 848,986 Value ($000) $17,031 Avg Close $18.93 Range $13.30 - $24.11
Q1 2025
Shares 848,986 Value ($000) $16,708 Avg Close $21.52 Range $18.67 - $25.37
Q4 2024
Shares 848,986 Value ($000) $19,102 Avg Close $25.92 Range $21.43 - $30.03
Q3 2024
Shares 1,061,233 Value ($000) $27,104 Avg Close $23.16 Range $20.63 - $27.67
Q2 2024
Shares 2,122,465 Value ($000) $49,602 Avg Close $21.05 Range $15.96 - $26.00
Q1 2024
Shares 2,122,465 Value ($000) $37,334 Avg Close $15.34 Range $10.90 - $19.50
Q4 2023
Shares 2,122,465 Value ($000) $29,375 Avg Close $12.23 Range $9.80 - $15.41
Q3 2023
Shares 2,122,465 Value ($000) $28,993 Avg Close $16.84 Range $12.38 - $20.77
Q2 2023
Shares 2,122,465 Value ($000) $43,320 Avg Close $20.21 Range $17.15 - $23.98
Q1 2023
Shares 2,122,465 Value ($000) $46,482 Avg Close $20.34 Range $14.56 - $25.34